Annual FCF:
$557.20M+$195.60M(+54.09%)Summary
- As of today, NBIX annual free cash flow is $557.20 million, with the most recent change of +$195.60 million (+54.09%) on December 31, 2024.
- During the last 3 years, NBIX annual free cash flow has risen by +$324.10 million (+139.04%).
- NBIX annual free cash flow is now at all-time high.
Performance
NBIX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$89.50M+$35.40M(+65.43%)Summary
- As of today, NBIX quarterly free cash flow is $89.50 million, with the most recent change of +$35.40 million (+65.43%) on June 30, 2025.
- Over the past year, NBIX quarterly free cash flow has increased by +$36.50 million (+68.87%).
- NBIX quarterly free cash flow is now -61.95% below its all-time high of $235.20 million, reached on December 31, 2024.
Performance
NBIX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$528.70M+$36.50M(+7.42%)Summary
- As of today, NBIX TTM free cash flow is $528.70 million, with the most recent change of +$36.50 million (+7.42%) on June 30, 2025.
- Over the past year, NBIX TTM free cash flow has increased by +$34.10 million (+6.89%).
- NBIX TTM free cash flow is now -13.95% below its all-time high of $614.40 million, reached on March 31, 2024.
Performance
NBIX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NBIX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +54.1% | +68.9% | +6.9% |
| 3Y3 Years | +139.0% | -30.8% | +298.7% |
| 5Y5 Years | +321.2% | -21.6% | +137.8% |
NBIX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +139.0% | -62.0% | +166.9% | -13.9% | +198.7% |
| 5Y | 5-Year | at high | +321.2% | -62.0% | +166.9% | -13.9% | +417.3% |
| All-Time | All-Time | at high | +463.9% | -62.0% | +166.9% | -13.9% | +376.6% |
NBIX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $89.50M(+65.4%) | $528.70M(+7.4%) |
| Mar 2025 | - | $54.10M(-77.0%) | $492.20M(-11.7%) |
| Dec 2024 | $557.20M(+54.1%) | $235.20M(+56.9%) | $557.20M(+26.6%) |
| Sep 2024 | - | $149.90M(+182.8%) | $440.10M(-11.0%) |
| Jun 2024 | - | $53.00M(-55.5%) | $494.60M(-19.5%) |
| Mar 2024 | - | $119.10M(+0.8%) | $614.40M(+69.9%) |
| Dec 2023 | $361.60M(+12.0%) | $118.10M(-42.2%) | $361.60M(-6.0%) |
| Sep 2023 | - | $204.40M(+18.3%) | $384.70M(+37.0%) |
| Jun 2023 | - | $172.80M(+229.2%) | $280.80M(+18.3%) |
| Mar 2023 | - | -$133.70M(-194.7%) | $237.30M(-26.5%) |
| Dec 2022 | $322.90M(+38.5%) | $141.20M(+40.5%) | $322.90M(+82.4%) |
| Sep 2022 | - | $100.50M(-22.3%) | $177.00M(+33.5%) |
| Jun 2022 | - | $129.30M(+368.8%) | $132.60M(+29.7%) |
| Mar 2022 | - | -$48.10M(-923.4%) | $102.20M(-56.2%) |
| Dec 2021 | $233.10M(+7.1%) | -$4.70M(-108.4%) | $233.10M(-28.9%) |
| Sep 2021 | - | $56.10M(-43.3%) | $327.80M(+30.6%) |
| Jun 2021 | - | $98.90M(+19.4%) | $250.90M(-5.7%) |
| Mar 2021 | - | $82.80M(-8.0%) | $266.20M(+22.3%) |
| Dec 2020 | $217.60M(+64.5%) | $90.00M(+532.7%) | $217.60M(-2.1%) |
| Sep 2020 | - | -$20.80M(-118.2%) | $222.30M(-34.1%) |
| Jun 2020 | - | $114.20M(+233.9%) | $337.40M(+19.3%) |
| Mar 2020 | - | $34.20M(-63.9%) | $282.90M(+113.8%) |
| Dec 2019 | $132.30M(+72.7%) | $94.70M(+0.4%) | $132.30M(+61.2%) |
| Sep 2019 | - | $94.30M(+58.0%) | $82.09M(+85.1%) |
| Jun 2019 | - | $59.70M(+151.3%) | $44.35M(+9025.5%) |
| Mar 2019 | - | -$116.40M(-361.6%) | $486.00K(-99.4%) |
| Dec 2018 | $76.60M(+175.6%) | $44.49M(-21.3%) | $76.60M(+9.0%) |
| Sep 2018 | - | $56.56M(+257.1%) | $70.31M(+4202.7%) |
| Jun 2018 | - | $15.84M(+139.3%) | $1.63M(+102.6%) |
| Mar 2018 | - | -$40.29M(-205.5%) | -$62.84M(+38.0%) |
| Dec 2017 | -$101.27M(+8.2%) | $38.20M(+415.3%) | -$101.27M(+40.9%) |
| Sep 2017 | - | -$12.11M(+75.1%) | -$171.44M(+10.3%) |
| Jun 2017 | - | -$48.64M(+38.2%) | -$191.11M(-20.2%) |
| Mar 2017 | - | -$78.72M(-146.2%) | -$159.06M(-44.2%) |
| Dec 2016 | -$110.29M(-176.2%) | -$31.97M(-0.6%) | -$110.29M(-16.9%) |
| Sep 2016 | - | -$31.79M(-91.7%) | -$94.35M(-15.8%) |
| Jun 2016 | - | -$16.58M(+44.7%) | -$81.45M(-58.4%) |
| Mar 2016 | - | -$29.95M(-86.8%) | -$51.42M(-28.8%) |
| Dec 2015 | -$39.93M(+18.1%) | -$16.03M(+15.1%) | -$39.93M(-0.7%) |
| Sep 2015 | - | -$18.89M(-240.4%) | -$39.65M(-19.7%) |
| Jun 2015 | - | $13.45M(+172.9%) | -$33.13M(+42.1%) |
| Mar 2015 | - | -$18.46M(-17.2%) | -$57.19M(-17.3%) |
| Dec 2014 | -$48.75M(-61.7%) | -$15.75M(-27.3%) | -$48.75M(-10.6%) |
| Sep 2014 | - | -$12.37M(-16.5%) | -$44.07M(-3.7%) |
| Jun 2014 | - | -$10.61M(-5.9%) | -$42.52M(-1.2%) |
| Mar 2014 | - | -$10.02M(+9.5%) | -$42.03M(-39.4%) |
| Dec 2013 | -$30.15M(+16.9%) | -$11.07M(-2.4%) | -$30.15M(-7.6%) |
| Sep 2013 | - | -$10.81M(-6.8%) | -$28.03M(-8.5%) |
| Jun 2013 | - | -$10.12M(-646.4%) | -$25.83M(-13.3%) |
| Mar 2013 | - | $1.85M(+120.7%) | -$22.80M(+37.1%) |
| Dec 2012 | -$36.27M(-2404.5%) | -$8.95M(-4.0%) | -$36.27M(-122.0%) |
| Sep 2012 | - | -$8.61M(-21.3%) | -$16.33M(-196.2%) |
| Jun 2012 | - | -$7.10M(+38.9%) | -$5.51M(-23.7%) |
| Mar 2012 | - | -$11.61M(-205.7%) | -$4.46M(-207.7%) |
| Dec 2011 | -$1.45M(-102.9%) | $10.98M(+396.8%) | -$1.45M(+91.5%) |
| Sep 2011 | - | $2.21M(+136.6%) | -$16.97M(+6.4%) |
| Jun 2011 | - | -$6.04M(+29.8%) | -$18.12M(-134.1%) |
| Mar 2011 | - | -$8.60M(-89.4%) | $53.22M(+7.2%) |
| Dec 2010 | $49.63M | -$4.54M(-530.3%) | $49.63M(+23.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $1.05M(-98.4%) | $40.20M(+43.4%) |
| Jun 2010 | - | $65.30M(+635.8%) | $28.03M(+155.1%) |
| Mar 2010 | - | -$12.19M(+12.8%) | -$50.90M(+4.2%) |
| Dec 2009 | -$53.13M(+29.6%) | -$13.97M(-25.8%) | -$53.13M(+4.4%) |
| Sep 2009 | - | -$11.11M(+18.5%) | -$55.59M(+6.1%) |
| Jun 2009 | - | -$13.63M(+5.4%) | -$59.20M(+3.7%) |
| Mar 2009 | - | -$14.41M(+12.3%) | -$61.45M(+18.6%) |
| Dec 2008 | -$75.49M(-25.9%) | -$16.43M(-11.6%) | -$75.49M(-19.0%) |
| Sep 2008 | - | -$14.73M(+7.3%) | -$63.42M(+10.1%) |
| Jun 2008 | - | -$15.88M(+44.2%) | -$70.51M(+4.1%) |
| Mar 2008 | - | -$28.45M(-552.6%) | -$73.49M(-22.6%) |
| Dec 2007 | -$59.96M(+41.5%) | -$4.36M(+80.0%) | -$59.96M(+17.3%) |
| Sep 2007 | - | -$21.82M(-15.7%) | -$72.48M(+14.4%) |
| Jun 2007 | - | -$18.86M(-26.4%) | -$84.69M(+12.0%) |
| Mar 2007 | - | -$14.92M(+11.6%) | -$96.29M(+6.0%) |
| Dec 2006 | -$102.44M(-169.4%) | -$16.89M(+50.4%) | -$102.44M(+8.1%) |
| Sep 2006 | - | -$34.02M(-11.7%) | -$111.44M(-232.8%) |
| Jun 2006 | - | -$30.46M(-44.6%) | -$33.48M(-5.9%) |
| Mar 2006 | - | -$21.07M(+18.6%) | -$31.61M(+16.9%) |
| Dec 2005 | -$38.03M(+75.2%) | -$25.88M(-158.9%) | -$38.03M(+18.7%) |
| Sep 2005 | - | $43.93M(+253.7%) | -$46.80M(+55.3%) |
| Jun 2005 | - | -$28.59M(-4.0%) | -$104.73M(+20.7%) |
| Mar 2005 | - | -$27.49M(+20.7%) | -$132.09M(+13.7%) |
| Dec 2004 | -$153.13M(-1050.4%) | -$34.65M(-147.4%) | -$153.13M(-11.3%) |
| Sep 2004 | - | -$14.01M(+75.0%) | -$137.56M(+2.3%) |
| Jun 2004 | - | -$55.94M(-15.2%) | -$140.83M(-14.1%) |
| Mar 2004 | - | -$48.54M(-154.4%) | -$123.44M(-827.3%) |
| Dec 2003 | -$13.31M(+84.3%) | -$19.08M(-10.4%) | -$13.31M(+53.0%) |
| Sep 2003 | - | -$17.27M(+55.2%) | -$28.33M(-3.8%) |
| Jun 2003 | - | -$38.54M(-162.6%) | -$27.28M(-157.5%) |
| Mar 2003 | - | $61.58M(+280.6%) | -$10.60M(+87.5%) |
| Dec 2002 | -$84.67M(-229.9%) | -$34.09M(-110.1%) | -$84.67M(-66.6%) |
| Sep 2002 | - | -$16.23M(+25.7%) | -$50.83M(-36.8%) |
| Jun 2002 | - | -$21.86M(-75.1%) | -$37.15M(-28.0%) |
| Mar 2002 | - | -$12.48M(-4796.1%) | -$29.03M(-13.1%) |
| Dec 2001 | -$25.66M(-21.7%) | -$255.00K(+90.0%) | -$25.66M(+19.8%) |
| Sep 2001 | - | -$2.55M(+81.4%) | -$31.98M(-0.3%) |
| Jun 2001 | - | -$13.74M(-50.8%) | -$31.88M(-15.1%) |
| Mar 2001 | - | -$9.12M(-38.7%) | -$27.69M(-31.3%) |
| Dec 2000 | -$21.09M(-70.0%) | -$6.57M(-168.4%) | -$21.09M(-68.5%) |
| Sep 2000 | - | -$2.45M(+74.4%) | -$12.51M(+15.2%) |
| Jun 2000 | - | -$9.55M(-280.0%) | -$14.76M(-43.1%) |
| Mar 2000 | - | -$2.51M(-225.7%) | -$10.31M(+16.8%) |
| Dec 1999 | -$12.40M(+13.9%) | $2.00M(+142.6%) | -$12.40M(+29.9%) |
| Sep 1999 | - | -$4.70M(+7.8%) | -$17.70M(-21.2%) |
| Jun 1999 | - | -$5.10M(-10.9%) | -$14.60M(-13.2%) |
| Mar 1999 | - | -$4.60M(-39.4%) | -$12.90M(+10.4%) |
| Dec 1998 | -$14.40M(-413.0%) | -$3.30M(-106.3%) | -$14.40M(-161.8%) |
| Sep 1998 | - | -$1.60M(+52.9%) | -$5.50M(-523.1%) |
| Jun 1998 | - | -$3.40M(+44.3%) | $1.30M(+138.2%) |
| Mar 1998 | - | -$6.10M(-208.9%) | -$3.40M(-173.9%) |
| Dec 1997 | $4.60M(+4.5%) | $5.60M(+7.7%) | $4.60M(-45.9%) |
| Sep 1997 | - | $5.20M(+164.2%) | $8.50M(+431.3%) |
| Jun 1997 | - | -$8.10M(-526.3%) | $1.60M(-82.6%) |
| Mar 1997 | - | $1.90M(-80.0%) | $9.20M(+109.1%) |
| Dec 1996 | $4.40M | $9.50M(+658.8%) | $4.40M(+186.3%) |
| Sep 1996 | - | -$1.70M(-240.0%) | -$5.10M(-50.0%) |
| Jun 1996 | - | -$500.00K(+82.8%) | -$3.40M(-17.2%) |
| Mar 1996 | - | -$2.90M | -$2.90M |
FAQ
- What is Neurocrine Biosciences, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. annual free cash flow year-on-year change?
- What is Neurocrine Biosciences, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. quarterly free cash flow year-on-year change?
- What is Neurocrine Biosciences, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. TTM free cash flow year-on-year change?
What is Neurocrine Biosciences, Inc. annual free cash flow?
The current annual free cash flow of NBIX is $557.20M
What is the all-time high annual free cash flow for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high annual free cash flow is $557.20M
What is Neurocrine Biosciences, Inc. annual free cash flow year-on-year change?
Over the past year, NBIX annual free cash flow has changed by +$195.60M (+54.09%)
What is Neurocrine Biosciences, Inc. quarterly free cash flow?
The current quarterly free cash flow of NBIX is $89.50M
What is the all-time high quarterly free cash flow for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high quarterly free cash flow is $235.20M
What is Neurocrine Biosciences, Inc. quarterly free cash flow year-on-year change?
Over the past year, NBIX quarterly free cash flow has changed by +$36.50M (+68.87%)
What is Neurocrine Biosciences, Inc. TTM free cash flow?
The current TTM free cash flow of NBIX is $528.70M
What is the all-time high TTM free cash flow for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high TTM free cash flow is $614.40M
What is Neurocrine Biosciences, Inc. TTM free cash flow year-on-year change?
Over the past year, NBIX TTM free cash flow has changed by +$34.10M (+6.89%)